These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7589215)

  • 1. Physostigmine, galanthamine and codeine act as 'noncompetitive nicotinic receptor agonists' on clonal rat pheochromocytoma cells.
    Storch A; Schrattenholz A; Cooper JC; Abdel Ghani EM; Gutbrod O; Weber KH; Reinhardt S; Lobron C; Hermsen B; Soskiç V
    Eur J Pharmacol; 1995 Aug; 290(3):207-19. PubMed ID: 7589215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Competitive potentiation of acetylcholine effects on neuronal nicotinic receptors by acetylcholinesterase-inhibiting drugs.
    Zwart R; van Kleef RG; Gotti C; Smulders CJ; Vijverberg HP
    J Neurochem; 2000 Dec; 75(6):2492-500. PubMed ID: 11080202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physostigmine and galanthamine: probes for a novel binding site on the alpha 4 beta 2 subtype of neuronal nicotinic acetylcholine receptors stably expressed in fibroblast cells.
    Pereira EF; Alkondon M; Reinhardt S; Maelicke A; Peng X; Lindstrom J; Whiting P; Albuquerque EX
    J Pharmacol Exp Ther; 1994 Aug; 270(2):768-78. PubMed ID: 8071869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncompetitive agonism at nicotinic acetylcholine receptors; functional significance for CNS signal transduction.
    Maelicke A; Schrattenholz A; Storch A; Schroder B; Gutbrod O; Methfessel C; Weber KH; Pereira EE; Alkondon M; Albuquerque EX
    J Recept Signal Transduct Res; 1995; 15(1-4):333-53. PubMed ID: 8903949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
    Akk G; Steinbach JH
    J Neurosci; 2005 Feb; 25(8):1992-2001. PubMed ID: 15728839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional characterization of a new agonist site on nicotinic acetylcholine receptors of cultured hippocampal neurons.
    Pereira EF; Reinhardt-Maelicke S; Schrattenholz A; Maelicke A; Albuquerque EX
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1474-91. PubMed ID: 8510023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physostigmine and galanthamine bind in the presence of agonist at the canonical and noncanonical subunit interfaces of a nicotinic acetylcholine receptor.
    Hamouda AK; Kimm T; Cohen JB
    J Neurosci; 2013 Jan; 33(2):485-94. PubMed ID: 23303929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physostigmine and acetylcholine differentially activate nicotinic receptor subpopulations in Locusta migratoria neurons.
    van den Beukel I; van Kleef RG; Zwart R; Oortgiesen M
    Brain Res; 1998 Apr; 789(2):263-73. PubMed ID: 9573380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physostigmine modulation of acetylcholine currents in COS cells transfected with mouse muscle nicotinic receptor.
    Svobodová L; Krůsek J; Hendrych T; Vyskocil F
    Neurosci Lett; 2006 Jun; 401(1-2):20-4. PubMed ID: 16530961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationship of reversible cholinesterase inhibitors: activation, channel blockade and stereospecificity of the nicotinic acetylcholine receptor-ion channel complex.
    Albuquerque EX; Aracava Y; Cintra WM; Brossi A; Schönenberger B; Deshpande SS
    Braz J Med Biol Res; 1988; 21(6):1173-96. PubMed ID: 3074841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists.
    Maelicke A; Coban T; Storch A; Schrattenholz A; Pereira EF; Albuquerque EX
    J Recept Signal Transduct Res; 1997; 17(1-3):11-28. PubMed ID: 9029479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic drugs potentiate human nicotinic alpha4beta2 acetylcholine receptors by a competitive mechanism.
    Smulders CJ; Zwart R; Bermudez I; van Kleef RG; Groot-Kormelink PJ; Vijverberg HP
    Eur J Pharmacol; 2005 Feb; 509(2-3):97-108. PubMed ID: 15733544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens.
    Caricati-Neto A; D'angelo LC; Reuter H; Hyppolito Jurkiewicz N; Garcia AG; Jurkiewicz A
    Eur J Pharmacol; 2004 Oct; 503(1-3):191-201. PubMed ID: 15496314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease.
    Maelicke A; Albuquerque EX
    Eur J Pharmacol; 2000 Mar; 393(1-3):165-70. PubMed ID: 10771010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of the nicotinic acetylcholine receptor from fetal rat muscle expressed in Xenopus oocytes.
    Cooper JC; Gutbrod O; Witzemann V; Methfessel C
    Eur J Pharmacol; 1996 Aug; 309(3):287-98. PubMed ID: 8874153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudophrynaminol: a potent noncompetitive blocker of nicotinic receptor-channels.
    Badio B; Garraffo HM; Padgett WL; Greig NH; Daly JW
    Biochem Pharmacol; 1997 Mar; 53(5):671-6. PubMed ID: 9113086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical characterization of a novel channel-activating site on nicotinic acetylcholine receptors.
    Schrattenholz A; Coban T; Schröder B; Okonjo KO; Kuhlmann J; Pereira EF; Albuquerque EX; Maelicke A
    J Recept Res; 1993; 13(1-4):393-412. PubMed ID: 7680720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetylcholinesterase inhibitors on the binding of nicotinic alpha4beta2 receptor PET radiotracer, (18)F-nifene: A measure of acetylcholine competition.
    Easwaramoorthy B; Pichika R; Collins D; Potkin SG; Leslie FM; Mukherjee J
    Synapse; 2007 Jan; 61(1):29-36. PubMed ID: 17068780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topology of ligand binding sites on the nicotinic acetylcholine receptor.
    Arias HR
    Brain Res Brain Res Rev; 1997 Oct; 25(2):133-91. PubMed ID: 9403137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization is a property of the cholinergic binding region of the nicotinic acetylcholine receptor, not of the receptor-integral ion channel.
    Kuhlmann J; Okonjo KO; Maelicke A
    FEBS Lett; 1991 Feb; 279(2):216-8. PubMed ID: 1705896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.